Diamyd Medical AB (publ.) (Pink Sheets:DMYDY) (STO:DIAMB): A renowned research group at Lund University has filed an application with the Swedish Medical Products Agency to carry out a study of the diabetes vaccine Diamyd® for the prevention of type 1 diabetes in Swedish children.[click link for full article]
Page Not Found
Diamyd Medical: New Study Application To Vaccinate Against Juvenile Diabetes With Diamyd®
Published at Januar 1st, 2009Women Can Contract Hiv Through Healthy Tissue, Study Says
Published at Dezember 19th, 2008A new study has found that HIV appears to attack normal, healthy genital tissue in women and does not require breaks in the skin to infiltrate cells, offering new perspectives on how the virus is spread, researchers said on Tuesday, Reuters reports. Thomas Hope, a study author from Northwestern University’s Feinberg School of Medicine, said [...]
Nobel Prize Winner Montagnier Predicts Therapeutic Hiv Vaccine In Four To Five Years
Published at Dezember 9th, 2008A therapeutic HIV vaccine could be developed within four to five years, Luc Montagnier, one of three recipients of the 2008 Nobel Prize in medicine, said Saturday at a News conference in Stockholm, Sweden, the AP/Kansas City Star reports (Nordstrom, AP/Kansas City Star, 12/6). According to Reuters, researchers are working to develop a vaccine [...]
U.k. Development Minister Launches $350m Fund For Hiv/aids Research
Published at November 6th, 2008United Kingdom Development Minister Gareth Thomas on Tuesday announced a new fund worth 220 million British pounds, or about $350 million, for research into technologies aimed at curbing the spread of HIV worldwide, London’s Guardian reports. The fund likely will be aimed at researchers who are developing new HIV/AIDS technologies — such as microbicides, [...]
Study Examines Why Merck Vaccine Candidate Might Have Increased Likelihood Of Contracting Hiv
Published at November 5th, 2008Trials of Merck’s experimental HIV vaccine were halted in September 2007 because the drug might have increased the likelihood of contracting the virus rather than preventing it, according to a study published Monday in the Journal of Experimental Medicine, AFP/Google.com reports.The vaccine was based on the idea that a modified form of a common cold [...]
Magazine Calls On Next President To Develop National Hiv/aids Plan
Published at November 5th, 2008Whichever candidate wins the U.S. presidential election should develop a national HIV/AIDS strategy, POZ magazine editor-in-chief Regan Hofmann said recently, VOA News reports. According to POZ, more than one million people in the U.S. are HIV-positive, and 14,000 people died from AIDS-related causes in 2006. In addition, about 25% of people in the [...]
Researchers At Hiv/aids Vaccine Conference Discuss New Methods, Ongoing Trials
Published at Oktober 21st, 2008Researchers at the AIDS Vaccine 2008 conference in Cape Town, South Africa, last week examined how setbacks in developing a vaccine have “forced them to look for entirely new ways of creating a defense against the disease,” AFP/Google.com reports. “We are in the middle of quite a profound shift of mindset in the research [...]
Researchers At Global Hiv/aids Vaccine Conference Express Concerns About Funding Levels
Published at Oktober 16th, 2008Experts at the AIDS Vaccine 2008 conference in Cape Town, South Africa, on Tuesday expressed concerns that the current global economic situation could damage funding for AIDS research and vaccine development, the AP/Los Angeles Times reports. The economic situation has “added to the gloom among experts deeply frustrated by … setbacks” in HIV/AIDS vaccine [...]
Canadian Hiv/aids Advocates Call For Increased Efforts From Next Government To Fight Hiv/aids
Published at Oktober 15th, 2008A coalition of Canadian HIV/AIDS organizations led by the Canadian AIDS Society on Thursday called for the country’s next elected government to reinstate social support and other resources for people living with HIV/AIDS, the CP/Yahoo! News reports. The call came after the coalition contacted Canada’s five main political parties to ask them about their [...]
Drug Companies Plan To Invest In Hiv/aids Drug Development, Improve Access, U.n. Secretary-general Says
Published at Oktober 11th, 2008United Nations Secretary-General Ban Ki-moon on Thursday said that many large pharmaceutical companies — including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline and Pfizer — plan to increase their efforts to develop HIV/AIDS drugs and diagnostics for impoverished regions, Reuters reports. The companies have promised to invest more in prevention efforts — including vaccine development and [...]